CN1226295C - 枸橼酸莫沙必利的制备方法 - Google Patents
枸橼酸莫沙必利的制备方法 Download PDFInfo
- Publication number
- CN1226295C CN1226295C CN 03111913 CN03111913A CN1226295C CN 1226295 C CN1226295 C CN 1226295C CN 03111913 CN03111913 CN 03111913 CN 03111913 A CN03111913 A CN 03111913A CN 1226295 C CN1226295 C CN 1226295C
- Authority
- CN
- China
- Prior art keywords
- preparation
- luorobenzyl
- acid
- dge
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03111913 CN1226295C (zh) | 2003-03-03 | 2003-03-03 | 枸橼酸莫沙必利的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03111913 CN1226295C (zh) | 2003-03-03 | 2003-03-03 | 枸橼酸莫沙必利的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1526700A CN1526700A (zh) | 2004-09-08 |
CN1226295C true CN1226295C (zh) | 2005-11-09 |
Family
ID=34283555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03111913 Expired - Lifetime CN1226295C (zh) | 2003-03-03 | 2003-03-03 | 枸橼酸莫沙必利的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1226295C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101538217B (zh) * | 2008-03-20 | 2015-04-15 | 成都弘达药业有限公司 | 2-乙氧基-4-氨基-5-氯苯甲酸的合成新方法及其中间体 |
CN101565381B (zh) * | 2009-06-01 | 2013-07-24 | 重庆英斯凯化工有限公司 | 2-烷氧基-4-氨基-5-氯苯甲酸的制备方法 |
CN102320986B (zh) * | 2011-07-25 | 2014-06-25 | 武汉武药科技有限公司 | 一种氯吡格雷中间体的制备方法 |
CN104693137A (zh) * | 2013-12-10 | 2015-06-10 | 沈阳药科大学 | 一种莫沙必利活性代谢物 |
CN104693064A (zh) * | 2013-12-10 | 2015-06-10 | 沈阳药科大学 | 莫沙必利的活性代谢物 |
CN108129414B (zh) * | 2018-02-09 | 2020-12-08 | 鲁南制药集团股份有限公司 | 一种枸橼酸莫沙必利中间体的制备方法 |
CN108341788A (zh) * | 2018-02-09 | 2018-07-31 | 鲁南制药集团股份有限公司 | 一种枸橼酸莫沙必利中间体及用途 |
CN111848432A (zh) * | 2020-07-15 | 2020-10-30 | 广药白云山化学制药(珠海)有限公司 | 一种对氨基水杨酸的制备方法 |
CN112225708B (zh) * | 2020-12-14 | 2021-04-09 | 上海翰森生物医药科技有限公司 | 一种莫沙必利中间体的制备方法 |
-
2003
- 2003-03-03 CN CN 03111913 patent/CN1226295C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1526700A (zh) | 2004-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101607955B (zh) | 一种低残留硫辛酸的制备方法 | |
CN1466570A (zh) | 晶体和纯莫达非尼及其制备方法 | |
CN1226295C (zh) | 枸橼酸莫沙必利的制备方法 | |
CN108424393A (zh) | 一种次氯酸荧光探针及其制备方法和应用 | |
CN113233975B (zh) | 一种贝派地酸的制备方法 | |
CN110330440A (zh) | 一种以5-氯甲基糠醛制备5-氨基乙酰丙酸的工艺 | |
CN101037445A (zh) | 一种具有潜在生物活性的咪唑并[2,1-b]-1,3,4-噻二唑衍生物及其合成方法 | |
CN108997229A (zh) | 1,2,3,4-四氢喹喔啉-6-羧酸甲酯及其制备方法 | |
CN109111431A (zh) | 一种盐酸巴尼地平化合物及其制备方法 | |
CN101492413B (zh) | 卡洛芬的精制方法 | |
CN1164585C (zh) | 椒苯酮胺、椒苯酮胺盐及其制备方法 | |
CN1915974A (zh) | 氨氯地平的拆分方法 | |
CN108129414B (zh) | 一种枸橼酸莫沙必利中间体的制备方法 | |
CN102391170B (zh) | 一种n,n-二烯丙基-5-甲氧基色胺盐酸盐的制备方法 | |
CN102010345A (zh) | 一种动态动力学拆分制备d-苯丙氨酸的方法 | |
CN1061985C (zh) | 一种降解甾体皂甙元成为孕甾醇的方法及其用途 | |
CN110437083A (zh) | 重酒石酸间羟胺对映异构体的合成方法 | |
CN114716449B (zh) | 一种2-甲氧基-6-乙二醇缩酮-5,7,8-三氢喹啉的制备方法 | |
CN1082045C (zh) | α-苯偶姻肟的合成方法 | |
CN101066943A (zh) | 2,4-二氯-5-磺酰胺基苯甲酸的合成方法 | |
CN106496089A (zh) | 一种制备奥拉西坦的方法 | |
CN104230909B (zh) | 一种阿齐沙坦的制备方法 | |
WO2005016937A1 (fr) | Procede de synthese de 6-chloro-4-hydroxy-2-methyl-2h-thienol(2,3-e)-1,2-thiazine-1,1-dioxyde-3-carboxylate | |
CN103242146A (zh) | 一种顺-3-己稀醛的制备方法 | |
CN101892276A (zh) | 一种阿托伐他汀钙化合物及其新方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20040908 Assignee: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Assignor: LUNAN PHARMACEUTICAL Group Corp. Contract record no.: 2013370000261 Denomination of invention: Synthesis of Important intermediate for mosapride citrate Granted publication date: 20051109 License type: Exclusive License Record date: 20131210 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161228 Address after: 276005 Hongqi Road, Shandong, Linyi, No. 209 Patentee after: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Address before: 276005 Hongqi Road, Shandong, Linyi, No. 209 Patentee before: LUNAN PHARMACEUTICAL Group Corp. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20051109 |